MSB 7.69% $1.19 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-989

  1. 6,745 Posts.
    lightbulb Created with Sketch. 1459
    what I find interesting FAR is that the fda gave an interim response (letter) to these lawyers claims (from memory 9 January 2021). An interim response because of the many varied fda priorities. So, really they just responded to acknowledge that there had been a letter sent to them (fda) but have not addressed the contents of the letter (due to being busy). But fda said they would follow up.

    There has been no further correspondence to lawyers from FDA since.

    weird!




 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.